Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age

Canadian Journal of Gastroenterology

Volumn 21, Issue 7, 2007, Pages 443-446

  Karvellas, Constantine J ^a   Fedorak, Richard N ^a   Hanson, John ^a   Wong, Clarence K W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Colarectal cancer; Dysplasia; Surveillance colonoscopy; Ulcerative colitis

Indexed keywords

IMMUNOMODULATING AGENT; MESALAZINE;

ADULT; ARTICLE; CANADA; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; GASTROINTESTINAL DYSPLASIA; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ULCERATIVE COLITIS;

EID: 34548159729     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/136406     Document Type: Article

References (24)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526-35.
2. Bernstein CN. Cancer surveillance in inflammatory bowel disease. Curr Gastroenterol Rep 1999;1:496-504.
3. Bus PJ, Nagtegaal ID, Verspaget HW, et al. Mesalazine-induced apoptosis of colorectal cancer: On the verge of a new chemopreventive era? Aliment Pharmacol Ther 1999;13:1397-402.
4. Delco F, Sonnenberg A. The unsolved problem of surveillance for colorectal cancer in ulcerative colitis. Can J Gastroenterol 1999;13:655-60.
5. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study. Am J Epidemiol 1999;149:916-24.
6. Bamba T, Nishiyama Y. [Clinical features and management of the elderly patients with ulcerative colitis.] Nippon Rinsho 1999;57:2598-602.
7. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001;61:3573-7.
8. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9.
9. Connell W. PRO: Endoscopic surveillance minimizes the risk of cancer. Am J Gastroenterol 2004;99:1631-3.
10. Ahlquist DA, Shuber AP. Stool screening for colorectal cancer: Evolution from occult blood to molecular markers. Clin Chim Acta 2002;315:157-68.
11. Ahlquist DA. Stool-based DNA tests for colorectal cancer: Clinical potential and early results. Rev Gastroenterol Disord 2002;2:S20-6.
12. Brand RE, Ross ME, Shuber AP. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection. Am J Gastroenterol 2004;99:1338-41.
13. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME; Colorectal. Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.
14. Fujii S, Fujimori T, Chiba T. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia. J Exp Clin Cancer Res 2003;22:107-15.
15. Fujii S, Fujimori T, Kashida H. Ulcerative colitis-associated neoplasia. Pathol Int 2002;52:195-203.
16. Fujii S, Fujimori T, Kawamata H, et al. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 2004;53:710-6.
17. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8.
18. Dekker E, Fockens P. New endoscopic tools for the IBD physician. Inflamm Bowel Dis 2004;10:S7-10.
19. Lashner BA. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 1993;119:549-54.
20. Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinski A. The effect of folic acid supplementation on the risk for cancer or clysplasia in ulcerative colitis. Gastroenterology 1997;112:29-32.
21. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: A case-control study. Aliment Pharmacol Ther 2000;14:145-53.
22. Croog VJ, Ullman TA, Itzkowitz SH. Chemoprevention of colorectal cancer in ulcerative colitis. Int J Colorectal Dis 2003;18:392-400.
23. Bernstein CN, Blanchard JF, Merge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003;98:2784-8.
24. Rubio CA, Befrits R, Ljung T, Jaramillo E, Slezak P. Colorectal carcinoma in ulcerative colitis is decreasing in Scandinavian countries. Anticancer Res 2001;21:2921-4.